Reference

First results of the radioimmunoassay for LH and FSH during hormone contraception

First results of the radioimmunoassay for LH and FSH during hormone contraception. Lauterbach, H.; Stoll, W.; Unverricht, A.; Carol, W.; Klinger, G.; Chemnitius, K. H. (Radiol. Klin., Friedrich-Schiller-Univ., Jena, E. Ger.). Vortragssamml. - Nuklearmed. Symp., 12th, Meeting Date 1975, 81-4. Edited by: Schwartz, Klaus Dieter. Isocommerz GmbH, Binnen- Aussenhandelsunternehmen Radioakt. Stabile Isot.: Berlin, E. Ger. (German) 1976. CODEN: 37MLAF. DOCUMENT TYPE: Conference CA Section: 2 (Hormone Pharmacology) Changes in FSH [9002-68-0] and LH [9002-67-9] secretion were detd. in women taking various forms of oral contraceptives (weekly pill regimen of ethynylestradiol sulfonate-norethisterone acetate mixt. [54958-72-4] (3 wk estrogen and 1 wk progestogen); a monthly regimen of Quinestrol [152-43-2]; and a combination prepn. Non-Ovlon [57637-90-8]). During the estrogen phase of all treatments, blood LH levels increased reaching ovulatory values, but no increase in FSH was obsd.

Comparison of quinestrol and Tace for relief of postpartum breast discomfort

Comparison of quinestrol and Tace for relief of postpartum breast discomfort. Grant, Kenneth; Rabello, Yolanda; Freeman, Angelita Galvan; Freeman, Roger K.; Baumgardner, Selina (Dep. Obstet. Gynecol., Univ. Southern California Sch. Med., Los Angeles, Calif., USA). Obstet. Gynecol. (Hagerstown, Md.), 51(5), 636-9 (English) 1978. CODEN: OBGNAS. ISSN: 0029-7844. DOCUMENT TYPE: Journal CA Section: 1 (Pharmacodynamics) A single 2-mg dose of quinestrol (I) [152-43-2] was safe and effective for controlling postpartum lactation and for alleviating breast discomfort. A double-blind comparison to Tace [569-57-3] 72 mg every 12 h for 2 days, and to placebo, was made in 134 patients. The single oral dose of I showed efficacy equal to the 2-day regimen of Tace. Both were superior to placebo.